Skip to main content
Top
Published in: CEN Case Reports 1/2021

01-02-2021 | Cancer Biomarker | Case Report

Cervical cancer of the uterus complicated by renal AA amyloidosis

Authors: Hajime Fujisawa, Atsuki Ohashi, Jun Ohta, Naohiro Muraki, Yuta Nakano, Kouhei Sugita, Saori Ishihara, Jiro Kumagai, Toshiyuki Fukutomi, Kiyotaka Nagahama

Published in: CEN Case Reports | Issue 1/2021

Login to get access

Abstract

Cervical cancer of the uterus rarely develops systemic secondary amyloidosis. We present the case of a 66-year-old female patient who manifested systemic amyloid A (AA) amyloidosis in the kidney, digestive tract, and cervix of the uterus, secondary to cervical cancer. She exhibited nephrotic syndrome, intractable diarrhea, and mild fever 3 months after she underwent an extended hysterectomy with postoperative cisplatin-based chemotherapy and whole pelvic irradiation. Further examinations revealed AA amyloidosis of the kidney and colon and cytomegalovirus infection in the colon. AA amyloid deposition was positive in the resected tissues of uterine cancer. The patient was diagnosed with systemic AA amyloidosis consecutive to cervical cancer. Despite a decrease in urinary protein after antiviral therapy, it increased 14 months later with neither apparent symptoms nor an increase in tumor marker. A second renal biopsy revealed AA amyloidosis of the kidney. Subsequent investigations revealed the recurrence of cervical cancer in the lung, liver, and lymph nodes. This case report indicated that AA amyloidosis would complicate cervical cancer and recur even after resection of neoplasm owing to other stimulation. Moreover, urine protein could be a marker for cancer relapse in known cases of cancer-derived AA amyloidosis.
Literature
1.
go back to reference Okuda Y, Yamada T, Ueda M, Ando Y. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Intern Med. 2018;57:3351–5.CrossRef Okuda Y, Yamada T, Ueda M, Ando Y. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Intern Med. 2018;57:3351–5.CrossRef
2.
go back to reference Dictor M, Hasserius R. Systemic amyloidosis and non-hematologic malignancy in a large autopsy series. Acta Pathol Microbiol Scand A. 1981;89:411–6.PubMed Dictor M, Hasserius R. Systemic amyloidosis and non-hematologic malignancy in a large autopsy series. Acta Pathol Microbiol Scand A. 1981;89:411–6.PubMed
3.
go back to reference Zuckerman JE, Peng F, Karl BE, Schulze CE, Sisk A. Cancer-associated AA amyloidosis presenting as crescentic glomerulonephritis. Kidney Int Rep. 2019;4:882–7.CrossRef Zuckerman JE, Peng F, Karl BE, Schulze CE, Sisk A. Cancer-associated AA amyloidosis presenting as crescentic glomerulonephritis. Kidney Int Rep. 2019;4:882–7.CrossRef
4.
go back to reference Karsenty G, Ulmann A, Droz D, Carnot F, Grünfeld JP. Clinical and histological resolution of systemic amyloidosis after renal cell carcinoma removal. Nephron. 1985;40:232–4.CrossRef Karsenty G, Ulmann A, Droz D, Carnot F, Grünfeld JP. Clinical and histological resolution of systemic amyloidosis after renal cell carcinoma removal. Nephron. 1985;40:232–4.CrossRef
5.
go back to reference Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82:226–34.CrossRef Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82:226–34.CrossRef
6.
go back to reference Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8:915–21.CrossRef Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8:915–21.CrossRef
7.
go back to reference Ren Y, Wang H, Lu D, Xie X, Chen X, Peng J, et al. Expression of serum amyloid A in uterine cervical cancer. Diagn Pathol. 2014;9:16.CrossRef Ren Y, Wang H, Lu D, Xie X, Chen X, Peng J, et al. Expression of serum amyloid A in uterine cervical cancer. Diagn Pathol. 2014;9:16.CrossRef
8.
go back to reference Papa R, Lachmann HJ. Secondary, AA, amyloidosis. Rheum Dis Clin N Am. 2018;44(4):585–603.CrossRef Papa R, Lachmann HJ. Secondary, AA, amyloidosis. Rheum Dis Clin N Am. 2018;44(4):585–603.CrossRef
9.
go back to reference Calderaro J, Letouzé E, Bayard Q, Boulai A, Renault V, Deleuze J-F, et al. Systemic AA amyloidosis caused by inflammatory hepatocellular adenoma. N Engl J Med. 2018;379:1178–80.CrossRef Calderaro J, Letouzé E, Bayard Q, Boulai A, Renault V, Deleuze J-F, et al. Systemic AA amyloidosis caused by inflammatory hepatocellular adenoma. N Engl J Med. 2018;379:1178–80.CrossRef
10.
go back to reference Kimball KG. Amyloidosis in association with neoplastic disease Report of an unusual case and clinicopathological experience at Memorial Center for Cancer and Allied Diseases during eleven years (1948–1958). Ann Intern Med. 1961;55:958–74.CrossRef Kimball KG. Amyloidosis in association with neoplastic disease Report of an unusual case and clinicopathological experience at Memorial Center for Cancer and Allied Diseases during eleven years (1948–1958). Ann Intern Med. 1961;55:958–74.CrossRef
11.
go back to reference Azzopardi JG, Lehner T. Systemic amyloidosis and malignant disease. J Clin Pathol. 1966;19:539–48.CrossRef Azzopardi JG, Lehner T. Systemic amyloidosis and malignant disease. J Clin Pathol. 1966;19:539–48.CrossRef
12.
go back to reference Sakemi T, Nakamura K, Baba N, Watanabe T. Rapidly progressive renal amyloidosis associated with uterine cervical cancer. Clin Nephrol. 1992;38:173–4.PubMed Sakemi T, Nakamura K, Baba N, Watanabe T. Rapidly progressive renal amyloidosis associated with uterine cervical cancer. Clin Nephrol. 1992;38:173–4.PubMed
13.
go back to reference Babu A, Lachmann H, Pickett T, Boddana P, Ludeman L. Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature. CEN Case Rep. 2014;3:68–74.CrossRef Babu A, Lachmann H, Pickett T, Boddana P, Ludeman L. Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature. CEN Case Rep. 2014;3:68–74.CrossRef
14.
go back to reference Fievet P, Sevestre H, Boudjelal M, Noel LH, Kemeny F, Franco D, et al. Systemic AA amyloidosis induced by liver cell adenoma. Gut. 1990;31:361–3.CrossRef Fievet P, Sevestre H, Boudjelal M, Noel LH, Kemeny F, Franco D, et al. Systemic AA amyloidosis induced by liver cell adenoma. Gut. 1990;31:361–3.CrossRef
15.
go back to reference Kisilevsky R. Preparation and propagation of amyloid-enhancing factor. Methods Mol Biol. 2005;299:237–41.PubMed Kisilevsky R. Preparation and propagation of amyloid-enhancing factor. Methods Mol Biol. 2005;299:237–41.PubMed
16.
go back to reference Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem. 1993;39:293–7.CrossRef Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem. 1993;39:293–7.CrossRef
17.
go back to reference Tajima S, Ushijima T, Matuya S, Horiuchi H. AA-type amyloidosis in association with non-Hodgkin’s lymphoma following CMV viremia: autopsy case. Pathol Int. 2010;60:222–7.CrossRef Tajima S, Ushijima T, Matuya S, Horiuchi H. AA-type amyloidosis in association with non-Hodgkin’s lymphoma following CMV viremia: autopsy case. Pathol Int. 2010;60:222–7.CrossRef
18.
go back to reference Gadducci A, Tana R, Fanucchi A, Genazzani AR. Biochemical prognostic factors and risk of relapses in patients with cervical cancer. Gynecol Oncol. 2007;107:S23–6.CrossRef Gadducci A, Tana R, Fanucchi A, Genazzani AR. Biochemical prognostic factors and risk of relapses in patients with cervical cancer. Gynecol Oncol. 2007;107:S23–6.CrossRef
Metadata
Title
Cervical cancer of the uterus complicated by renal AA amyloidosis
Authors
Hajime Fujisawa
Atsuki Ohashi
Jun Ohta
Naohiro Muraki
Yuta Nakano
Kouhei Sugita
Saori Ishihara
Jiro Kumagai
Toshiyuki Fukutomi
Kiyotaka Nagahama
Publication date
01-02-2021
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 1/2021
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-020-00530-5

Other articles of this Issue 1/2021

CEN Case Reports 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.